Enríquez RJA, Yamallel OLÁ, Vázquez MOT, Garza RV, Ocampo CJ, Ancer AJ

Language: Spanish
References: 15
Page: 172-177
PDF size: 353.47 Kb.

ABSTRACT

Background: Mohs micrographic surgery is a fundamental tool for the treatment of non-melanoma skin cancer. Although it has been performed in Mexico for many years, the information on patient follow-up is very scarce.
Material and methods: we analyzed the characteristics of patients treated with Mohs surgery at the Department of Dermatology of the University Hospital Dr. José Eleuterio González from January 2014 to December 2018.
Results: 408 Mohs surgeries were performed during this period. 85% of them were basal cell carcinomas and 9.1% were squamous cell carcinomas and 5.9% were made up of other tumors. Of the total of patients, 347 (85.1%) had follow-up after surgery. Recurrence was documented in eight patients (2.3%) and occurred on average at 21.6 months. Only 19.6% of our patients had follow-up for more than 24 months.
Conclusions: Mohs surgery has proven effective for the treatment of our population. However, optimal follow-up is not performed in a large percentage of patients. Despite being a study with a short period of vigilance, this paper shows that patients in our region do not attend follow-up correctly, so it is essential to educate the population.

REFERENCES

1. Marrazzo G, Zitelli JA y Brodland D, Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone, J Am Acad Dermatol 2019; 80:633-8.

2. Van Lee CB, Roorda BM, Wakkee M, et al., Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study, Br J Dermatol 2019; 181:338-43.

3. Rowe DE, Carroll RJ y Day CL, Jr., Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma, J Dermatol Surg Oncol 1989; 15:424-31.

4. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S y Paver R, Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years, J Am Acad Dermatol 2005; 53:253-60.

5. Rowe DE, Carroll RJ y Day CL, Jr., Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection, J Am Acad Dermatol 1992; 26:976-90.

6. Tschetter AJ, Campoli MR, Zitelli JA y Brodland DG, Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study, J Am Acad Dermatol 2020; 82:139-48.

7. Paoli J, Daryoni S, Wennberg AM et al., 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma, Acta Derm Venereol 2011; 91: 689-93.

8. Ocampo-Candiani J, Vidaurri LM y Medrano Olazarán Z, Cirugía micrográfica de Mohs en tumores malignos de piel, Med Cutan Iber Lat Am 2004; 32:65-70.

9. Cortés-Peralta EC, Garza-Rodríguez V, Vázquez-Martínez OT, Gutiérrez- Villarreal IM y Ocampo-Candiani J, Mohs micrographic surgery: 27 year experience in the Northeast of Mexico, Cir Cir 2017; 85:279-83.

10. Ruiz-Salas V, Garcés JR, Minano Medrano R et al., Description of patients undergoing Mohs surgery in Spain: initial report on data from the Spanish Registry of Mohs Surgery (Regesmohs), Actas Dermosifiliogr 2015; 106:562-8.

11. Smeets NW, Kuijpers DI, Nelemans P et al., Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face: results of a retrospective study and review of the literature, Br J Dermatol 2004; 151:141-7.

12. Catalá A, Garcés JR, Alegre M, Gich IJ y Puig L, Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan-Meier survival analysis of tumour recurrence, J Eur Acad Dermatol Venereol 2014; 28:1363-9.

13. Mosterd K, Krekels GA, Nieman FH et al., Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up, Lancet Oncol 2008; 9:1149-56.

14. Cernea SS, Gontijo G, Pimentel ER et al., Indication guidelines for Mohs micrographic surgery in skin tumors, An Bras Dermatol 2016; 91:621-7.

15. Mueller CK, Nicolaus K, Thorwarth M y Schultze-Mosgau S, Multivariate analysis of the influence of patient-, tumor-, and managementrelated factors on the outcome of surgical therapy for facial basal-cell carcinoma, Oral Maxillofac Surg 2010; 14:163-8.